Adapthealth Corp Stock Price, News & Analysis

AdaptHealth Corp. (NASDAQ: AHCO) announced its initial guidance for fiscal year 2023, projecting net revenue between $3.210 billion and $3.290 billion, alongside Adjusted EBITDA estimates of $690 million to $750 million. Factors influencing this guidance include changes in reimbursement and regulatory frameworks. For fiscal year 2022, anticipated net revenue is projected near $3.010 billion, with Adjusted EBITDA near $620 million. The full results for 2022 will be released on February 28, 2023.

AdaptHealth Corp. (NASDAQ: AHCO) announced that CEO Steve Griggs will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 3:00 PM PT. The presentation will be available via a live webcast on the company's investor website. AdaptHealth specializes in patient-centered healthcare-at-home solutions, providing a range of medical equipment and supplies to help manage chronic conditions. The company serves approximately 3.9 million patients annually across the United States through a network of 750 locations.

AdaptHealth Corp. (NASDAQ: AHCO) will participate in a fireside chat at the BofA Securities Home Care Conference on December 5 at 2:00 pm ET. CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will represent the company. A live webcast and replay will be available on AdaptHealth's investors page, with attendees encouraged to register early. AdaptHealth is a leading provider of healthcare-at-home solutions, serving approximately 3.9 million patients annually across 750 locations in 47 states.

AdaptHealth Corp. (NASDAQ: AHCO) reported record net revenue of $756.5 million for Q3 2022, up 15.8% from $653.3 million in Q3 2021. However, net income dropped to $16.1 million ($0.11 per share) from $58.1 million ($0.20 per share) year-over-year. Adjusted EBITDA increased slightly to $160.2 million, while cash flow from operations rose significantly to $107.0 million. The company updated its fiscal year 2022 guidance, projecting net revenue between $2.950 billion and $3.010 billion, reflecting strong demand in the healthcare-at-home market.

AdaptHealth Corp. (NASDAQ: AHCO) will announce its third quarter 2022 financial results before the market opens on November 8, 2022. Management will hold a teleconference at 8:30 a.m. ET to discuss the results and ongoing business activities with analysts and investors. AdaptHealth is a leader in providing healthcare-at-home solutions, serving around 3.9 million patients annually through over 750 locations in 47 states, focusing on home medical equipment, medical supplies, and related services.

AdaptHealth Corp. (NASDAQ: AHCO) announced new long-term financial goals during its 2022 Capital Markets Day. CEO Steve Griggs highlighted the company's progress in establishing a scalable foundation for profitable growth and shareholder value. The company aims to lead the shift to connected in-home healthcare, emphasizing its commitment to cost-effective patient care. AdaptHealth serves approx. 3.9 million patients annually, leveraging operational excellence and strategic acquisitions. The firm is focused on enhancing its chronic disease management programs and expanding its connected care offerings.

AdaptHealth Corp. (NASDAQ: AHCO) will host its first Capital Markets Day on September 16, 2022, at 9:00 a.m. ET. The event aims to present the Company’s business model, market position, and long-term strategies for growth and profitability. CEO Steve Griggs emphasizes the importance of connecting with investors and analysts. The event will be webcast live, with additional materials available on AdaptHealth’s website. This initiative reflects AdaptHealth's commitment to providing healthcare-at-home solutions and reaching approximately 3.9 million patients annually across the U.S.

AdaptHealth Corp. (NASDAQ: AHCO) reported second-quarter financial results for 2022, highlighting a net revenue of $727.6 million, a 17.9% increase from $617.0 million in 2021. Adjusted EBITDA rose 1.8% to $150.0 million, with an EBITDA margin improvement to 20.6%. However, net income dropped to $14.0 million from $79.1 million year-over-year. Non-acquired net revenue slightly decreased by 0.3%. The company maintained its 2022 guidance, projecting net revenue between $2.840 billion and $3.040 billion.

AdaptHealth Corp. (NASD: AHCO) will be added to the S&P SmallCap 600 index, effective August 4, 2022. This change comes as Cummins Inc. (NYSE: CMI) is acquiring Meritor Inc. (NYSE: MTOR), which is being removed from the index. The transition reflects a strategic reshuffle in the S&P indices as AdaptHealth enhances its presence in the health care sector. The acquisition of Meritor by Cummins is expected to complete soon, pending closing conditions.